• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测孤立性肝细胞癌患者肝切除术后超早期复发的临床-放射学特征

Clinical-Radiological Characteristic for Predicting Ultra-Early Recurrence After Liver Resection in Solitary Hepatocellular Carcinoma Patients.

作者信息

Wang Xinxin, Yu Yanyan, Tao Yuqing, Wang Yueqi, Zhang Chunhui, Cui Yali, Zhou Yang

机构信息

Department of Radiology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, People's Republic of China.

Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, People's Republic of China.

出版信息

J Hepatocell Carcinoma. 2023 Dec 21;10:2323-2335. doi: 10.2147/JHC.S434955. eCollection 2023.

DOI:10.2147/JHC.S434955
PMID:38146465
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10749548/
Abstract

OBJECTIVE

This study aims to identify independent risk factors for ultra-early recurrence in patients with early solitary hepatocellular carcinoma (HCC) and develop an individualized predictive nomogram for ultra-early recurrence.

MATERIALS AND METHODS

A total of 332 patients with early solitary HCC who underwent curative liver resection at our hospital from January 2015 to May 2021 were included in this study. Based on the patients' recurrence status at 6 months, they were divided into the non-ultra-early recurrence group and the ultra-early recurrence group. Univariate and multivariate Cox regression analyses were used to construct the nomogram, and internal validation of its performance was performed using calibration plots with bootstrapping.

RESULTS

Among the 332 patients with early solitary HCC, 39 (11.7%) experienced ultra-early recurrence. Tumor morphology, age > 46 years, AFP > 332.4 ng/mL, GGT > 51.2 U/L, ALP > 126 U/L, PT > 12.8 s, and satellite nodules were identified as independent prognostic factors for ultra-early recurrence in patients with early solitary HCC and were incorporated into the final predictive nomogram. The C-index of the nomogram and bootstrap resampling were 0.842 and 0.815, respectively. The calibration plot demonstrated good agreement between the predicted and observed probabilities of ultra-early recurrence, and DCA indicated the favorable clinical utility of the nomogram. Additionally, AFP > 332.4 ng/mL, AST > 35 U/L, GGT > 51.2 U/L, ALP > 126 U/L, tumor morphology, tumor size, satellite nodules, and intratumoral hemorrhage were identified as risk factors for overall survival in patients with early solitary HCC.

CONCLUSION

Our study establishes a nomogram for predicting the postoperative ultra-early recurrence status in patients with early solitary HCC, which provides valuable supplementary decision-making information for clinical decision-makers and guides the selection of the most appropriate treatment strategy.

摘要

目的

本研究旨在确定早期孤立性肝细胞癌(HCC)患者超早期复发的独立危险因素,并开发一种用于预测超早期复发的个体化预测列线图。

材料与方法

本研究纳入了2015年1月至2021年5月在我院接受根治性肝切除术的332例早期孤立性HCC患者。根据患者6个月时的复发状态,将其分为非超早期复发组和超早期复发组。采用单因素和多因素Cox回归分析构建列线图,并使用自抽样校准图对其性能进行内部验证。

结果

在332例早期孤立性HCC患者中,39例(11.7%)发生超早期复发。肿瘤形态、年龄>46岁、甲胎蛋白(AFP)>332.4 ng/mL、γ-谷氨酰转移酶(GGT)>51.2 U/L、碱性磷酸酶(ALP)>126 U/L、凝血酶原时间(PT)>12.8 s以及卫星结节被确定为早期孤立性HCC患者超早期复发的独立预后因素,并被纳入最终的预测列线图。列线图的C指数和自抽样重采样分别为0.842和0.815。校准图显示超早期复发的预测概率与观察概率之间具有良好的一致性,决策曲线分析(DCA)表明列线图具有良好的临床实用性。此外,AFP>332.4 ng/mL、天门冬氨酸氨基转移酶(AST)>35 U/L、GGT>51.2 U/L、ALP>126 U/L、肿瘤形态、肿瘤大小、卫星结节以及瘤内出血被确定为早期孤立性HCC患者总生存的危险因素。

结论

我们的研究建立了一种用于预测早期孤立性HCC患者术后超早期复发状态的列线图,为临床决策者提供了有价值的辅助决策信息,并指导选择最合适的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/897d/10749548/ed2668282a69/JHC-10-2323-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/897d/10749548/217e63b2a7e3/JHC-10-2323-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/897d/10749548/ca2a06a0ad2b/JHC-10-2323-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/897d/10749548/7e70ad3f789a/JHC-10-2323-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/897d/10749548/ed2668282a69/JHC-10-2323-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/897d/10749548/217e63b2a7e3/JHC-10-2323-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/897d/10749548/ca2a06a0ad2b/JHC-10-2323-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/897d/10749548/7e70ad3f789a/JHC-10-2323-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/897d/10749548/ed2668282a69/JHC-10-2323-g0004.jpg

相似文献

1
Clinical-Radiological Characteristic for Predicting Ultra-Early Recurrence After Liver Resection in Solitary Hepatocellular Carcinoma Patients.预测孤立性肝细胞癌患者肝切除术后超早期复发的临床-放射学特征
J Hepatocell Carcinoma. 2023 Dec 21;10:2323-2335. doi: 10.2147/JHC.S434955. eCollection 2023.
2
Construction of a predictive nomogram and bioinformatic investigation of the potential mechanism of postoperative early recurrence of hepatocellular carcinoma meeting the Milan criteria.符合米兰标准的肝细胞癌术后早期复发预测列线图的构建及潜在机制的生物信息学研究
Ann Transl Med. 2022 Aug;10(16):866. doi: 10.21037/atm-22-3390.
3
Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma.基于白蛋白-胆红素(ALBI)和单核细胞与淋巴细胞比值(MLR)的列线图模型预测甲胎蛋白阴性肝细胞癌的肿瘤复发情况
J Hepatocell Carcinoma. 2021 Nov 12;8:1355-1365. doi: 10.2147/JHC.S339707. eCollection 2021.
4
Pre- to postoperative alpha-fetoprotein ratio-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma.基于术前至术后甲胎蛋白比值的列线图预测肝细胞癌患者的肿瘤复发情况
Front Oncol. 2023 Apr 14;13:1134933. doi: 10.3389/fonc.2023.1134933. eCollection 2023.
5
A Predictive Nomogram of Early Recurrence for Patients with AFP-Negative Hepatocellular Carcinoma Underwent Curative Resection.接受根治性切除的甲胎蛋白阴性肝细胞癌患者早期复发的预测列线图。
Diagnostics (Basel). 2022 Apr 25;12(5):1073. doi: 10.3390/diagnostics12051073.
6
[The study of nomogram based on Ishak inflammation score for recurrence of hepatocellular carcinoma after curative resection].基于Ishak炎症评分的列线图对肝细胞癌根治性切除术后复发的研究
Zhonghua Wai Ke Za Zhi. 2018 Feb 1;56(2):124-129. doi: 10.3760/cma.j.issn.0529-5815.2018.02.009.
7
Development and validation of a nomogram for survival prediction in hepatocellular carcinoma after partial hepatectomy.开发并验证肝癌部分肝切除术后生存预测的列线图。
BMC Surg. 2023 Jan 30;23(1):27. doi: 10.1186/s12893-023-01922-x.
8
Nomogram Based on Platelet-Albumin-Bilirubin for Predicting Tumor Recurrence After Surgery in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients.基于血小板-白蛋白-胆红素的列线图预测甲胎蛋白阴性肝细胞癌患者术后肿瘤复发情况
J Hepatocell Carcinoma. 2023 Jan 13;10:43-55. doi: 10.2147/JHC.S396433. eCollection 2023.
9
Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus-Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor Thrombus.新型模型预测乙型肝炎病毒相关≤10cm 单发肝细胞癌且无门静脉癌栓患者的术后复发和总生存期。
Oncologist. 2020 Oct;25(10):e1552-e1561. doi: 10.1634/theoncologist.2019-0766. Epub 2020 Aug 6.
10
A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.基于影像组学的Nomogram 模型预测肝癌患者肝切除术后的总生存情况
Cancer Imaging. 2020 Nov 16;20(1):82. doi: 10.1186/s40644-020-00360-9.

引用本文的文献

1
A Clinical-Imaging Nomogram for Predicting Early Recurrence in Patients with Solitary Hepatocellular Carcinoma After Postoperative Adjuvant TACE.一种用于预测孤立性肝细胞癌患者术后辅助性经动脉化疗栓塞术后早期复发的临床影像列线图。
J Hepatocell Carcinoma. 2025 Aug 19;12:1835-1847. doi: 10.2147/JHC.S544127. eCollection 2025.

本文引用的文献

1
Association of tumor morphology with long-term prognosis after liver resection for patients with a solitary huge hepatocellular carcinoma-a multicenter propensity score matching analysis.孤立性巨大肝细胞癌患者肝切除术后肿瘤形态与长期预后的相关性——一项多中心倾向评分匹配分析
Hepatobiliary Surg Nutr. 2023 Jun 1;12(3):314-327. doi: 10.21037/hbsn-21-423. Epub 2022 Feb 15.
2
LI-RADS Morphological Type Predicts Prognosis of Patients with Hepatocellular Carcinoma After Radical Resection.LI-RADS 形态学类型预测肝癌患者根治性切除术后的预后。
Ann Surg Oncol. 2023 Aug;30(8):4876-4885. doi: 10.1245/s10434-023-13494-4. Epub 2023 May 3.
3
Predictors of early and late hepatocellular carcinoma recurrence.
预测早期和晚期肝细胞癌复发的因素。
World J Gastroenterol. 2023 Feb 28;29(8):1243-1260. doi: 10.3748/wjg.v29.i8.1243.
4
Predictive models and early postoperative recurrence evaluation for hepatocellular carcinoma based on gadoxetic acid-enhanced MR imaging.基于钆塞酸二钠增强磁共振成像的肝细胞癌预测模型及术后早期复发评估
Insights Imaging. 2023 Jan 8;14(1):4. doi: 10.1186/s13244-022-01359-5.
5
Neoadjuvant Therapy for Hepatocellular Carcinoma.肝细胞癌的新辅助治疗
J Hepatocell Carcinoma. 2022 Aug 31;9:929-946. doi: 10.2147/JHC.S357313. eCollection 2022.
6
Nomograms for Predicting Hepatocellular Carcinoma Recurrence and Overall Postoperative Patient Survival.预测肝细胞癌复发及患者术后总体生存的列线图
Front Oncol. 2022 Feb 28;12:843589. doi: 10.3389/fonc.2022.843589. eCollection 2022.
7
Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma Are Prognostic after Surgery.钆塞酸增强 MRI 特征对手术后增殖型肝细胞癌具有预后价值。
Radiology. 2021 Sep;300(3):572-582. doi: 10.1148/radiol.2021204352. Epub 2021 Jul 6.
8
Macrotrabecular-massive hepatocellular carcinoma: imaging identification and prediction based on gadoxetic acid-enhanced magnetic resonance imaging.巨梁型/块状型肝细胞癌:基于钆塞酸增强磁共振成像的影像学特征识别与预测。
Eur Radiol. 2021 Oct;31(10):7696-7704. doi: 10.1007/s00330-021-07898-7. Epub 2021 Apr 15.
9
Adjuvant treatment strategy after curative resection for hepatocellular carcinoma.根治性切除术后肝细胞癌的辅助治疗策略。
Front Med. 2021 Apr;15(2):155-169. doi: 10.1007/s11684-021-0848-3. Epub 2021 Mar 23.
10
Changes in and challenges regarding the surgical treatment of hepatocellular carcinoma in China.中国肝细胞癌外科治疗的变化与挑战。
Biosci Trends. 2021 Jul 6;15(3):142-147. doi: 10.5582/bst.2021.01083. Epub 2021 Mar 14.